Related Experiment Videos
Release of acetylhydrolase from platelets on aggregation with platelet-activating factor
1Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Science, Japan.
European Journal of Biochemistry
|February 15, 1988
Summary
Platelet-activating factor acetylhydrolase is released from bovine platelets upon aggregation. This enzyme, important for regulating platelet activity, functions broadly and is inhibited by specific antagonists.
Area of Science:
- Biochemistry
- Hematology
- Enzymology
Background:
- Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and thrombosis.
- Acetylhydrolase is the primary enzyme responsible for inactivating PAF.
- Understanding the release and function of platelet acetylhydrolase is crucial for platelet biology.
Purpose of the Study:
- To investigate the selective release of acetylhydrolase from bovine platelets.
- To characterize the enzymatic properties of released acetylhydrolase.
- To explore the physiological relevance of platelet-derived acetylhydrolase.
Main Methods:
- Bovine platelets were aggregated using physiological concentrations of PAF, ADP, or thrombin.
- Acetylhydrolase activity in the supernatant was measured.
- Enzyme kinetics (Km) and inhibition by PAF antagonists (CV-3988, ONO-6040) were determined.
- Effect of Ca2+ and EDTA on enzyme activity was assessed.
Main Results:
- PAF (0.1-10 nM) induced selective release of active acetylhydrolase without cell lysis.
- Serotonin release paralleled acetylhydrolase release.
- The enzyme exhibited broad pH activity (5.4-8.6) and was unaffected by Ca2+ or EDTA.
- Km was 4.6 microM; Ki values for antagonists were 1.17 microM (CV-3988) and 0.84 microM (ONO-6040).
- Enzyme release was also observed upon ADP or thrombin aggregation.
Conclusions:
- Bovine platelets release functional acetylhydrolase upon aggregation.
- This released enzyme may play a physiological role in modulating PAF activity in blood plasma.
- The findings provide insights into platelet-mediated inflammatory and hemostatic processes.